Bioaffinity Technologies Inc (BIAF) Stock Price, Quote & News

Company Profile

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indica...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 210 698 5334

Website: bioaffinitytech.com

Address:

3300 Nacogdoches Road, Suite 216, San Antonio, United States

TooMuchSeaWater Aug. 3 at 9:02 PM

$BIAF they have to pump the shares otherwise they be delisted from NASDAQ. Even though they have a good sales of their product

1 · Reply

TooMuchSeaWater Aug. 3 at 8:55 PM

$BIAF they received a notice from NASDAQ that their stock is under $1 and they aren’t allowed to continue their listing within NASDAQ. BIAF replied for an appealing to NASDAQ on August 6th, which is this coming Thursday. Take a lesson from your investors, not to screw with them!!

1 · Reply

Hotresearchsgoldenage Aug. 3 at 3:46 PM

$BIAF sell order over 900,000 at 62.5 .

1 · Reply

Hotresearchsgoldenage Jul. 29 at 9:54 PM

$BIAF .40 incoming unless news hits . Yields just hit the highest ever sine 2007 and the financial crises .

1 · Reply

Hotresearchsgoldenage Jul. 29 at 5:08 PM

$BIAF the investors who purchased at .80 everyone was bitching about are already down close to 25% . They liked it at .80 and I’m sure they love it now .

1 · Reply

Stonecrest Jul. 28 at 2:31 PM

$BIAF there is a good chance that they have more cash on hand than the market cap of the company. They have no debt to speak of. This company has some issues for sure but that’s crazy.

1 · Reply

prismmarketview Jul. 27 at 2:46 PM

$BIAF bioAffinity Technologies released a new CyPath® Lung clinical framework for nodule risk stratification and lung cancer surveillance. This could help support adoption in the field. #biotech #diagnostics #investing https://prismmarketview.com/bioaffinity-technologies-highlights-a-new-clinical-framework-for-cypath-lung/

0 · Reply

STACKD0E Jul. 27 at 12:23 PM

$EDBL $TURB $YYAI $VERU $BIAF ✨️

0 · Reply

MrTicker Jul. 27 at 12:08 PM

$BIAF bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung BUSINESS WIRE 7:08 AM ET 7/27/2026

0 · Reply